CELL INTELLIGENCE · 肿瘤细胞治疗研究

儿童脑肿瘤的局部区域和全身过继性细胞疗法：CAR-T、TCR 工程 T 细胞和 NK 细胞策略的系统综述

Locoregional and systemic adoptive cellular therapies for pediatric brain tumors: a systematic review of CAR‑T, TCR‑engineered T cells, and NK cell st

CAR-T 细胞治疗胶质母细胞瘤、胶质瘤：I 期临床试验（City of Hope）

Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma

这是一项 I 期注册临床试验，评估 CAR-T 细胞治疗胶质母细胞瘤、胶质瘤的安全性、可行性及初步疗效。当前状态：进行中（不再招募）。计划入组 65 例。试验地点：美国 · 杜阿尔特（共 1 个中心）。登记号：NCT02208362。

CAR-T 细胞治疗儿童脑肿瘤：附临床试验入组标准比较分析的叙述性综述

CAR T-cell therapy in pediatric brain tumors: a narrative review with comparative analysis of clinical trial eligibility criteria.

整合 IL13RA2 的基因工程小鼠模型支持靶向儿童高级别胶质瘤的 CAR-T 细胞

IL13RA2-integrated genetically engineered mouse model allows for CAR T cells targeting pediatric high-grade gliomas.

支持靶向儿童高级别胶质瘤 CAR-T 细胞的 IL13RA2 整合基因工程小鼠模型

IL13RA2-integrated genetically engineered mouse model allows for CAR T cells targeting pediatric high-grade gliomas.

原发性脑肿瘤的 CAR-T 细胞治疗：当前研究与未来

CAR T Cell Therapy in Primary Brain Tumors: Current Investigations and the Future.